Evidence map›Paper›PMID 40083947›Full record

ArticleSchizophrenia bulletin open2025

Associations Between Klotho Levels,

Vijaya Majumdar, Prosenjeet Chakroborty, Rashmi Arasappa, K Murugesh, Shanthala Hegde, Amrutha Jose, N K Manjunath, Arpitha Dharmappa

Abstract read
In one paragraph

Article in Schizophrenia bulletin open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vijaya MajumdarMolecular Bioscience and Gerosceince lab, Swami Vivekananda Yoga Anusandhana Samsthana, Bangalore, Karnataka 560105, India.ORCID https://orcid.org/0000-0002-8594-5761
Prosenjeet ChakrobortyMolecular Bioscience and Gerosceince lab, Swami Vivekananda Yoga Anusandhana Samsthana, Bangalore, Karnataka 560105, India.
Rashmi ArasappaDepartment of Psychiatry, National Institute of Mental Health and NeuroSciences, Bangalore, Karnataka 560029, India.
K MurugeshMolecular Bioscience and Gerosceince lab, Swami Vivekananda Yoga Anusandhana Samsthana, Bangalore, Karnataka 560105, India.
Shanthala HegdeDepartment of Clinical Psychology, National Institute of Mental Health and NeuroSciences, Bangalore, Karnataka 560029, India.
Amrutha JoseBiostatistics, ICMR-National Institute of Immunohematology, Mumbai, Maharashtra 400012, India.
N K ManjunathMolecular Bioscience and Gerosceince lab, Swami Vivekananda Yoga Anusandhana Samsthana, Bangalore, Karnataka 560105, India.
Arpitha DharmappaMolecular Bioscience and Gerosceince lab, Swami Vivekananda Yoga Anusandhana Samsthana, Bangalore, Karnataka 560105, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Hypothesis: The relationship between Klotho and cognitive dysfunction in schizophrenia has been scarcely explored, with a few paradoxical findings. Hence, we aimed to enhance our understanding by testing associations between the functional KL-VS gene variant and circulating protein levels. Research Design: This case-control study included 239 healthy controls and 241 patients with schizophrenia, who were comprehensively characterized by neurocognitive tests and further subtyped into cognitive clusters; cognitively deficient (CD) and cognitively spared (CS), using Results: There was no main effect of KL-VS Conclusions: Overall, these dissociable patterns of association across cognitive domains indicate the need to exert caution over accepting any generalised direction of effect of Klotho at gene or protein level on cognition in schizophrenia.

Indexed as

cognitive subtypesKlothoKL-VSschizophrenia

Identifiers

PMID40083947
PMCPMC11904889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.